230 related articles for article (PubMed ID: 3276070)
1. Associations between cyclosporine therapy and interstitial fibrosis in renal allograft biopsies.
Ruiz P; Kolbeck PC; Scroggs MW; Sanfilippo F
Transplantation; 1988 Jan; 45(1):91-5. PubMed ID: 3276070
[TBL] [Abstract][Full Text] [Related]
2. Molecular and structural consequences of early renal allograft injury.
Baboolal K; Jones GA; Janezic A; Griffiths DR; Jurewicz WA
Kidney Int; 2002 Feb; 61(2):686-96. PubMed ID: 11849412
[TBL] [Abstract][Full Text] [Related]
3. Acute cellular rejection or Cyclosporine A nephrotoxicity? A review of transplant renal biopsies.
Verani RR; Flechner SM; Van Buren CT; Kahan BD
Am J Kidney Dis; 1984 Sep; 4(2):185-91. PubMed ID: 6383031
[TBL] [Abstract][Full Text] [Related]
4. Morphology of cyclosporine nephrotoxicity and acute rejection in patients immunosuppressed with cyclosporine and prednisone.
Sibley RK; Rynasiewicz J; Ferguson RM; Fryd D; Sutherland DE; Simmons RL; Najarian JS
Surgery; 1983 Aug; 94(2):225-34. PubMed ID: 6348988
[TBL] [Abstract][Full Text] [Related]
5. Nature and mediators of renal lesions in kidney transplant patients given cyclosporine for more than one year.
Benigni A; Bruzzi I; Mister M; Azzollini N; Gaspari F; Perico N; Gotti E; Bertani T; Remuzzi G
Kidney Int; 1999 Feb; 55(2):674-85. PubMed ID: 9987092
[TBL] [Abstract][Full Text] [Related]
6. Predictors of renal transplant histology at three months.
Kuypers DR; Chapman JR; O'Connell PJ; Allen RD; Nankivell BJ
Transplantation; 1999 May; 67(9):1222-30. PubMed ID: 10342313
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic contribution of renal allograft biopsies at various intervals after transplantation.
Kon SP; Templar J; Dodd SM; Rudge CJ; Raftery MJ
Transplantation; 1997 Feb; 63(4):547-50. PubMed ID: 9047149
[TBL] [Abstract][Full Text] [Related]
8. Interstitial fibrosis in renal allografts after 12 to 46 months of cyclosporin treatment: beneficial effect of low doses in early post-transplantation period.
Klintmalm G; Bohman SO; Sundelin B; Wilczek H
Lancet; 1984 Oct; 2(8409):950-4. PubMed ID: 6149343
[TBL] [Abstract][Full Text] [Related]
9. Cyclosporin and renal graft histology.
d'Ardenne AJ; Dunnill MS; Thompson JF; McWhinnie D; Wood RF; Morris PJ
J Clin Pathol; 1986 Feb; 39(2):145-51. PubMed ID: 3512612
[TBL] [Abstract][Full Text] [Related]
10. Expression of multidrug resistance P-glycoprotein in kidney allografts from cyclosporine A-treated patients.
Koziolek MJ; Riess R; Geiger H; Thévenod F; Hauser IA
Kidney Int; 2001 Jul; 60(1):156-66. PubMed ID: 11422747
[TBL] [Abstract][Full Text] [Related]
11. Immunopathologic patterns of cyclosporine deposition associated with nephrotoxicity in renal allograft biopsies.
Kolbeck PC; Wolfe JA; Burchette J; Sanfilippo F
Transplantation; 1987 Feb; 43(2):218-24. PubMed ID: 3544379
[TBL] [Abstract][Full Text] [Related]
12. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
[TBL] [Abstract][Full Text] [Related]
13. Utility of Serial Protocol Biopsies Performed After 1 Year in Predicting Long-Term Kidney Allograft Function According to Histologic Phenotype.
Zachariah MS; Dwivedi AK; Yip CS; Chang SS; Gundroo A; Venuto RC; Tomaszewski J; Patel SK; Sharma R
Exp Clin Transplant; 2018 Aug; 16(4):391-400. PubMed ID: 29206090
[TBL] [Abstract][Full Text] [Related]
14. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria.
Morrissey PE; Gohh R; Shaffer D; Crosson A; Madras PN; Sahyoun AI; Monaco AP
Transplantation; 1997 Mar; 63(6):845-8. PubMed ID: 9089224
[TBL] [Abstract][Full Text] [Related]
15. Renal histopathology in kidney transplant recipients immunosuppressed with cyclosporin A: results of an international workshop.
Clin Nephrol; 1985 Sep; 24(3):107-19. PubMed ID: 3899437
[TBL] [Abstract][Full Text] [Related]
16. TGF-beta1 expression in renal allograft rejection and cyclosporine A toxicity.
Ozdemir BH; Ozdemir FN; Demirhan B; Haberal M
Transplantation; 2005 Dec; 80(12):1681-5. PubMed ID: 16378061
[TBL] [Abstract][Full Text] [Related]
17. Circulating donor-specific anti-HLA antibodies are a major factor in premature and accelerated allograft fibrosis.
Gosset C; Viglietti D; Rabant M; Vérine J; Aubert O; Glotz D; Legendre C; Taupin JL; Duong Van-Huyen JP; Loupy A; Lefaucheur C
Kidney Int; 2017 Sep; 92(3):729-742. PubMed ID: 28554738
[TBL] [Abstract][Full Text] [Related]
18. Increased renal tubular expression of transforming growth factor beta in human allografts correlates with cyclosporine toxicity.
Pankewycz OG; Miao L; Isaacs R; Guan J; Pruett T; Haussmann G; Sturgill BC
Kidney Int; 1996 Nov; 50(5):1634-40. PubMed ID: 8914030
[TBL] [Abstract][Full Text] [Related]
19. T-bet-positive mononuclear cell infiltration is associated with transplant glomerulopathy and interstitial fibrosis and tubular atrophy in renal allograft recipients.
Yadav B; Prasad N; Agrawal V; Jain M; Agarwal V; Jaiswal A; Bhadauria D; Sharma RK; Gupta A
Exp Clin Transplant; 2015 Apr; 13(2):145-51. PubMed ID: 25871366
[TBL] [Abstract][Full Text] [Related]
20. Morphological findings in non-episode biopsies of kidney transplant allografts treated with FK506 or cyclosporine.
Kyo M; Hatori M; Takahara S; Kyakuno M; Nakamura T; Okada M; Kokado Y; Toki K; Ding XQ; Miki T; Miyamoto M; Okuyama A
Transpl Int; 1998; 11 Suppl 1():S100-3. PubMed ID: 9664955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
